NuCana plc (NASDAQ: NCNA)
$1.2400
-0.0300 ( -2.36% ) 43.6K
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Market Data
Open
$1.2400
Previous close
$1.2700
Volume
43.6K
Market cap
$4.83M
Day range
$1.2350 - $1.4240
52 week range
$1.0600 - $19.4100
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 4 | Nov 25, 2024 |
| 6-k | Form 6-K | 2 | Nov 12, 2024 |
| 6-k | Form 6-K | 1 | Oct 01, 2024 |
| 6-k | Form 6-K | 2 | Sep 26, 2024 |
| 6-k | Form 6-K | 2 | Sep 16, 2024 |
| 6-k | Form 6-K | 2 | Aug 29, 2024 |
| 6-k | Form 6-K | 51 | Aug 15, 2024 |
| 6-k | Form 6-K | 1 | Jun 18, 2024 |
| 6-k | Form 6-K | 4 | May 16, 2024 |
| 6-k | Form 6-K | 28 | May 13, 2024 |